Table of Contents
2019-2024 Global Retinal Biologics Market Report (Status and Outlook)
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Economic Indicators
1.6 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Retinal Biologics Market Size 2014-2024
2.1.2 Retinal Biologics Market Size CAGR by Region
2.2 Retinal Biologics Segment by Type
2.2.1 Macular Degeneration
2.2.2 Diabetic Retinopathy
2.2.3 Diabetic Macular Edema
2.2.4 Uveitis
2.2.5 Others
2.3 Retinal Biologics Market Size by Type
2.3.1 Global Retinal Biologics Market Size Market Share by Type (2014-2019)
2.3.2 Global Retinal Biologics Market Size Growth Rate by Type (2014-2019)
2.4 Retinal Biologics Segment by Application
2.4.1 Hospitals
2.4.2 Clinics
2.4.3 Others
2.5 Retinal Biologics Market Size by Application
2.5.1 Global Retinal Biologics Market Size Market Share by Application (2014-2019)
2.5.2 Global Retinal Biologics Market Size Growth Rate by Application (2014-2019)
3 Global Retinal Biologics by Players
3.1 Global Retinal Biologics Market Size Market Share by Players
3.1.1 Global Retinal Biologics Market Size by Players (2017-2019)
3.1.2 Global Retinal Biologics Market Size Market Share by Players (2017-2019)
3.2 Global Retinal Biologics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Retinal Biologics by Regions
4.1 Retinal Biologics Market Size by Regions
4.2 Americas Retinal Biologics Market Size Growth
4.3 APAC Retinal Biologics Market Size Growth
4.4 Europe Retinal Biologics Market Size Growth
4.5 Middle East & Africa Retinal Biologics Market Size Growth
5 Americas
5.1 Americas Retinal Biologics Market Size by Countries
5.2 Americas Retinal Biologics Market Size by Type
5.3 Americas Retinal Biologics Market Size by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Retinal Biologics Market Size by Countries
6.2 APAC Retinal Biologics Market Size by Type
6.3 APAC Retinal Biologics Market Size by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Countries
7 Europe
7.1 Europe Retinal Biologics by Countries
7.2 Europe Retinal Biologics Market Size by Type
7.3 Europe Retinal Biologics Market Size by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Retinal Biologics by Countries
8.2 Middle East & Africa Retinal Biologics Market Size by Type
8.3 Middle East & Africa Retinal Biologics Market Size by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Global Retinal Biologics Market Forecast
10.1 Global Retinal Biologics Market Size Forecast (2019-2024)
10.2 Global Retinal Biologics Forecast by Regions
10.2.1 Global Retinal Biologics Forecast by Regions (2019-2024)
10.2.2 Americas Market Forecast
10.2.3 APAC Market Forecast
10.2.4 Europe Market Forecast
10.2.5 Middle East & Africa Market Forecast
10.3 Americas Forecast by Countries
10.3.1 United States Market Forecast
10.3.2 Canada Market Forecast
10.3.3 Mexico Market Forecast
10.3.4 Brazil Market Forecast
10.4 APAC Forecast by Countries
10.4.1 China Market Forecast
10.4.2 Japan Market Forecast
10.4.3 Korea Market Forecast
10.4.4 Southeast Asia Market Forecast
10.4.5 India Market Forecast
10.4.6 Australia Market Forecast
10.5 Europe Forecast by Countries
10.5.1 Germany Market Forecast
10.5.2 France Market Forecast
10.5.3 UK Market Forecast
10.5.4 Italy Market Forecast
10.5.5 Russia Market Forecast
10.5.6 Spain Market Forecast
10.6 Middle East & Africa Forecast by Countries
10.6.1 Egypt Market Forecast
10.6.2 South Africa Market Forecast
10.6.3 Israel Market Forecast
10.6.4 Turkey Market Forecast
10.6.5 GCC Countries Market Forecast
10.7 Global Retinal Biologics Forecast by Type
10.8 Global Retinal Biologics Forecast by Application
11 Key Players Analysis
11.1 Spark Therapeutics, Inc
11.1.1 Company Details
11.1.2 Retinal Biologics Product Offered
11.1.3 Spark Therapeutics, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2019)
11.1.4 Main Business Overview
11.1.5 Spark Therapeutics, Inc News
11.2 F. Hoffmann-La Roche Ltd
11.2.1 Company Details
11.2.2 Retinal Biologics Product Offered
11.2.3 F. Hoffmann-La Roche Ltd Retinal Biologics Revenue, Gross Margin and Market Share (2017-2019)
11.2.4 Main Business Overview
11.2.5 F. Hoffmann-La Roche Ltd News
11.3 Regeneron Pharmaceuticals, Inc
11.3.1 Company Details
11.3.2 Retinal Biologics Product Offered
11.3.3 Regeneron Pharmaceuticals, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2019)
11.3.4 Main Business Overview
11.3.5 Regeneron Pharmaceuticals, Inc News
11.4 AbbVie Inc
11.4.1 Company Details
11.4.2 Retinal Biologics Product Offered
11.4.3 AbbVie Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2019)
11.4.4 Main Business Overview
11.4.5 AbbVie Inc News
11.5 Johnson & Johnson Services, Inc
11.5.1 Company Details
11.5.2 Retinal Biologics Product Offered
11.5.3 Johnson & Johnson Services, Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2019)
11.5.4 Main Business Overview
11.5.5 Johnson & Johnson Services, Inc News
11.6 Amgen Inc
11.6.1 Company Details
11.6.2 Retinal Biologics Product Offered
11.6.3 Amgen Inc Retinal Biologics Revenue, Gross Margin and Market Share (2017-2019)
11.6.4 Main Business Overview
11.6.5 Amgen Inc News
...
12 Research Findings and Conclusion
